All Stories

  1. A Recent Update on the Clinical Trials and Effectiveness of Drugs Used in COVID-19, MERS and SARS Coronaviruses

    Article • Anti-Infective Agents, April 2022, Bentham Science Publishers

    Ali Farmoudeh, Hamid Irannejad, Aala Azari, Seyed Sajad Hosseini Balef

  2. Pharmacologic Activities of 5, 6-Diaryl/heteroaryl-3-substituted-1, 2, 4- triazines as a Privileged Scaffold in Drug Development

    Article • Mini-Reviews in Medicinal Chemistry, November 2021, Bentham Science Publishers

    Hamid Irannejad

  3. Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma

    Article • Anti-Cancer Agents in Medicinal Chemistry, January 2020, Bentham Science Publishers

    Seyed Jalal HOSSEINIMEHR, Nima Naderi, Hamid Irannejad

  4. Genoprotective Effect of New Triazine Derivatives in Endosulfan Mediated Toxicity, an In vivo and In vitro Study

    Article • Letters in Drug Design & Discovery, November 2018, Bentham Science Publishers

    Hamid Irannejad, seyed mostafa ghasemi najarkolaee, Nima Naderi

  5. In vitro and in silico evaluation of P-glycoprotein inhibition through 99m Tc-methoxyisobutylisonitrile uptake

    Article • Chemical Biology & Drug Design, October 2018, Wiley

    Hamid Irannejad, Seyed Jalal HOSSEINIMEHR

  6. A crystallographic and theoretical study of an (E)-2-Hydroxyiminoethanone derivative: prediction of cyclooxygenase inhibition selectivity of stilbenoids by MM-PBSA and the role of atomic charge

    Article • Journal of Biomolecular Structure and Dynamics, April 2018, Taylor & Francis

    Hamid Irannejad, Seyed Sajad Hosseini Balef

  7. Design, Synthesis andIn VitroStudy of 5,6-Diaryl-1,2,4-triazine-3-ylthioacetate Derivatives as COX-2 and β-Amyloid Aggregation Inhibitors

    Article • Archiv der Pharmazie, February 2015, Wiley

    Hamid Irannejad

  8. 1,2-Diaryl-2-hydroxyiminoethanones as Dual COX-1 and β -Amyloid Aggregation Inhibitors: Biological Evaluation and In Silico Study

    Article • Chemical Biology & Drug Design, October 2014, Wiley

    Hamid Irannejad